Scientists utilized both RNA interference and lipid–polymer nanoparticles to engineer a potential multiple myeloma therapy, which targets cyclophilin A within blood vessels of the bone marrow.
[Proceedings Of The National Academy Of Sciences Of The United States Of America]
